India, Feb. 19 -- Sonic Healthcare Limited (SHL.AX,SKHCF.PK), an Australian provider of laboratory, pathology, and radiology services, reported that its net profit for the half year ended 31 December 2024 increased to A$237 million from A$202 million in the prior year.
Revenue for the period grew to A$4.669 billion from A$4.306 billion in the prior year.
The company has maintained its progressive dividend policy, announcing an increase of 1 cent (2.3%) to 44 cents per share for the 2025 interim dividend.
The company stated that it is on track to achieve its full-year 2025 EBITDA guidance, projected to be in the range of A$1.70 billion - A$1.75 billion on a constant currency basis.
Looking ahead, the company expects ongoing earnings grow...